Systemic underfunding of global HIV/AIDS programs: Congressional disruption reveals structural neglect of public health equity

Indigenous health systems in Southern Africa have historically provided holistic care for opportunistic infections, yet their integration into global HIV/AIDS frameworks is systematically excluded in favor of Western pharmaceutical models. Traditional healers in Lesotho and Botswana, who treat 80% of the rural population, have developed protocols for HIV-related complications that remain unrecognized by PEPFAR. The exclusion of indigenous knowledge reinforces a colonial epistemology that devalues non-Western medical traditions.

The HIV/AIDS crisis is inseparable from the legacy of structural adjustment programs in the 1980s–90s, which dismantled public health systems in Africa under IMF/World Bank directives. PEPFAR’s 2003 launch coincided with the U.S. War on Terror, repurposing global health funding to serve military and corporate interests—e.g., prioritizing male circumcision over female-controlled prevention methods. The 'AIDS exceptionalism' narrative of the 1990s framed the disease as a moral failing, delaying treatment access for marginalized groups like sex workers and injection drug users.

In Haiti, community health workers (ASCs) have reduced HIV transmission by 40% through peer-led education and local clinic networks, yet their model is ignored in favor of top-down U.S. programs. Brazil’s 1996 patent law reform allowed generic ARVs to be produced locally, cutting costs by 95%—a strategy the U.S. has actively undermined in trade agreements. The Global South’s emphasis on 'health as a human right' contrasts with the U.S. model of 'health as a market good,' yet this dichotomy is erased in Western media.

Peer-reviewed studies confirm that patent monopolies on ARVs inflate prices by 1000–3000%, pricing out 90% of patients in low-income countries. The WHO’s 'Treat All' guidelines, adopted in 2016, were delayed by U.S. lobbying to protect pharmaceutical profits. Research from the *Lancet* shows that conditional aid tied to privatization reduces healthcare worker retention by 30% in recipient nations, yet this evidence is sidelined in policy debates.

Artists like South Africa’s Zanele Muholi and Uganda’s Stella Nyanzi have used their work to challenge stigma and demand accountability for HIV/AIDS policy failures, framing the crisis as a violation of human dignity. In Brazil, Afro-Brazilian Candomblé communities have integrated spiritual healing into HIV care, yet this syncretic approach is dismissed as 'unscientific' by Western medicine. The erasure of spiritual dimensions in HIV/AIDS discourse reflects a broader colonial devaluation of indigenous cosmologies.

Modeling by the *Journal of the International AIDS Society* predicts that if current funding trends continue, 15 million additional HIV-related deaths will occur by 2035, with 80% in sub-Saharan Africa. Scenario planning by UNAIDS suggests that patent pooling and technology transfer could reduce ARV costs to $50/year, saving 5 million lives annually. The rise of AI-driven drug discovery could bypass Big Pharma monopolies, but this requires dismantling intellectual property regimes that currently stifle innovation.

Black and Indigenous women in the U.S. and Global South bear the brunt of HIV/AIDS funding cuts, yet their leadership in grassroots organizations is systematically underfunded. Sex workers in Kenya and India have pioneered peer-led prevention programs with 70% efficacy rates, yet their work is criminalized and defunded. The erasure of LGBTQ+ voices—especially in countries like Uganda where anti-homosexuality laws are tied to HIV funding—reveals how stigma is weaponized to silence those most affected.